Research project

Therapeutic targeting of a novel myeloid immune-checkpoint to overcome chemoresistance in breast cancer


Lead researcher

Dr Ali Roghanian PhD, FHEA

Associate Professor

Research interests

  • Cancer immunotherapy
  • Monoclonal antibodies
  • Immunoinhibitory receptors
Connect with Ali
Other researchers

Professor Stephen Beers

Professor of Immunology & Immunotherapy
Connect with Stephen

Dr Matthew Rose-Zerilli BSc (Hons), PhD

Lecturer in Integrative Cancer Biology

Research interests

  • Cancer prevention
  • Innate immunity
  • Tumour microenvironment
Connect with Matthew

Research outputs